News
AstraZeneca’s Calquence gets Japanese approval to treat adult patients...
AstraZeneca’s Calquence (acalabrutinib), a next-generation, selective Bruton’s tyrosine kinase (BTK) inhibitor, has been approved in Japan for the treatment of adult patients with relapsed or...
News
Care Access Research, AstraZeneca Partner on COVID-19 Antibody Trial
Care Access Research, a decentralized research organization (DRO) that connects physicians and research experts, entered a collaboration with AstraZeneca to accelerate a clinical trial in...
News
SPT Labtech Announces a Co-Marketing Initiative with Thermo Fisher...
The cost of library preparation is one of the biggest obstacles to large next-generation sequencing (NGS) studies, slowing down the pace of insights from infectious...
News
Pfizer and BioNTech Reach Agreement with COVAX for Advance...
Pfizer and BioNTech SE announced an advance purchase agreement with COVAX for up to 40 million doses of the Pfizer-BioNTech COVID-19 Vaccine. The doses will...
News
Ubiquigent and the University of York awarded grant to...
Ubiquigent Limited (Ubiquigent) and the Mottram Laboratory at the University of York announced a collaboration to investigate the inhibition of deubiquitylase (DUB) enzymes expressed by...
News
Pelican BioThermal Partnership with Asiana Airlines Announced
Pelican BioThermal, the global name in temperature controlled packaging, announces its latest partnership with Asiana Airlines, which will see an extensive expansion of the company’s...
Drug Research
Enara and Boehringer Ingelheim sign oncology partnership
Enara and Boehringer Ingelheim have teamed up to discover and develop novel cancer immunotherapies against overlooked dark antigen targets. How could dark antigens improve the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.














